An Assessment of Implant Stability and Bone Density using CGF and I-PRF in Sinus Augmentation Procedure - A Randomized Control Trial - NI

Dr Unnati Agarwal0 个研究点目标入组 10 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•1.Patients willing for voluntary participation & have signed informed consent for the described procedure.
•2.Patients having good physical and mental health and well-formed or moderately formed residual alveolar ridge
•3.Systemically healthy subjects.
•4.Patients requiring Sinus augmentation prior to placement of implant.
•5.Patients well motivated for implant therapy and maintaining good oral hygiene.
•6.Patients requiring bilateral sinus lift

•1.Immunocompromised patients.
•2.Grafted site (previous or during implant placement).
•3.Patients of chronic and aggressive periodontitis.
•4.Flapless procedures.
•5.Alcohol or drug abuse.
•6.Psychologically compromised patients.
•7.Patients with temporomandibular disorders, severe residual ridge resorption, orofacial tumors and gross facial deformity, mucositis, radiation therapy, parafunctional habit, etc.
•8.Patients with active diseases of the implant bed (e.g., residual cysts)
•9.Cancer Patients (ongoing chemotherapy)
•10.Patients on steroid therapy
•11.Severe Metabolic Diseases
•12.Immunocompromised patients
•13.Abnormal Platelet Function
•14.Bisphosphonates Therapy

发起方

Dr Unnati Agarwal